| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 88,211 | $29.45 | $2,597,473.97 | -10.4% | |
| Jul 1, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 56,789 | $29.81 | $1,692,704.72 | -8.5% | |
| Jun 30, 2016 | Shaff Eric D.66 | CFO And EVP | Sale+OE | 4,533 | $29.54 | $133,904.82 | -100% | |
| Jun 28, 2016 | Shaff Eric D.66 | CFO And EVP | Sale+OE | 5,001 | $28.28 | $141,444.95 | -100% | |
| Jun 27, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 9,390 | $27.23 | $255,689.70 | -22.3% | |
| Jun 2, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 74,049 | $32.52 | $2,407,915.67 | -10.4% | |
| Jun 2, 2016 | Cook David N | Chief Scientific Officer &EVP | Sell | 8,000 | $31.00 | $248,000.00 | -5.5% | |
| Jun 1, 2016 | Cook David N | Chief Scientific Officer &EVP | Sell | 16,000 | $29.43 | $470,880.00 | -10.0% | |
| Jun 1, 2016 | Pomerantz Roger | President And CEO | Sale+OE | 70,951 | $30.51 | $2,164,837.85 | -14.5% | |
| May 31, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 14,015 | $30.05 | $421,087.80 | -14.2% |